ENvue Medical (FEED) Return on Capital Employed (2015 - 2026)
ENvue Medical (FEED) posted quarterly Return on Capital Employed of 73.58% for Q1 2026, down 4252.0% year-over-year from 1.77% in Q1 2025, and down 32.11% quarter-over-quarter from 55.7% in Q4 2025.
ENvue Medical (FEED) Return on Capital Employed (2015 - 2026) Analysis & Trends
ENvue Medical (FEED) has reported Return on Capital Employed for 12 consecutive years, with 73.58% the latest figure, recorded in Q1 2026.
- In Q1 2026, Return on Capital Employed fell 4252.0% year-over-year to 73.58%; the TTM figure through Mar 2026 stood at 73.58% (down 4252.0% YoY), while the FY2025 annual figure was 145.64%, up 180.0% from the prior year.
- Return on Capital Employed slipped to 73.58% in Q1 2026 per FEED's latest filing, from 55.7% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 19.8% in Q2 2025 and bottomed at 249.88% in Q4 2024.
- Historically, Return on Capital Employed has averaged 107.48% across 5 years, with a median of 89.33% in 2022.
- Annual changes were most pronounced in 2024 — Return on Capital Employed plunged 17458 bps — and 2025, when it jumped 19418 bps.
- ENvue Medical's Return on Capital Employed stood at 155.24% in 2022, then surged by 51 bps to 75.29% in 2023, then slumped by 232 bps to 249.88% in 2024, then soared by 78 bps to 55.7% in 2025, then slumped by 32 bps to 73.58% in 2026.
- Business Quant data shows FEED's Return on Capital Employed at 73.58% in Q1 2026, 55.7% in Q4 2025, and 22.88% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.75 Bn | 194.14 Bn | 7.27 Bn | 7.98% |
| 2 | Stryker | 127.36 Bn | 123.88 Bn | 4.50 Bn | 13.69% |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 73.20 Bn | 72.66 Bn | 3.85 Bn | 10.83% |
| 5 | Edwards Lifesciences | 52.10 Bn | 47.85 Bn | 1.35 Bn | 11.99% |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | 27.21% |
| 7 | GE HealthCare Technologies | 33.77 Bn | 31.66 Bn | 2.18 Bn | 9.47% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 12.84% |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 12.08% |
| 10 | ENvue Medical | 2.49 Mn | 1.35 Mn | -266,000.00 | -82.45% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -82.45% |
| Mar 31, 2026 | -73.58% |
| Dec 31, 2025 | -55.70% |
| Sep 30, 2025 | -22.88% |
| Jun 30, 2025 | -19.80% |
| Mar 31, 2025 | -31.06% |
| Dec 31, 2024 | -249.88% |
| Sep 30, 2024 | -109.22% |
| Jun 30, 2024 | -76.67% |
| Mar 31, 2024 | -73.22% |
| Dec 31, 2023 | -75.29% |
| Sep 30, 2023 | -138.64% |
| Jun 30, 2023 | -240.70% |
| Mar 31, 2023 | -162.14% |
| Dec 31, 2022 | -155.24% |
| Sep 30, 2022 | -139.73% |
| Jun 30, 2022 | -114.03% |
| Mar 31, 2022 | -89.33% |
| Dec 31, 2021 | -78.48% |
| Sep 30, 2021 | -59.04% |